Loading...
•
Sep 30, 2020
STERIS Q2 2021 Earnings Report
STERIS's Q2 2021 financial results were announced, featuring a revenue increase and earnings per share growth.
Key Takeaways
STERIS plc reported a 3% increase in revenue to $756.1 million for the second quarter of fiscal 2021, with a net income of $105.9 million, or $1.23 per diluted share. Adjusted net income increased to $127.3 million, or $1.48 per diluted share. The revenue growth was driven by Life Sciences and Applied Sterilization Technologies, offsetting a decline in Healthcare.
Second quarter revenue increased by 3% as reported, with a 2% increase on a constant currency organic basis.
Earnings per diluted share increased to $1.23 on a U.S. GAAP basis and $1.48 on an adjusted basis.
Revenue growth was driven by Life Sciences and Applied Sterilization Technologies, offsetting a decline in Healthcare.
STERIS's Board of Directors has approved a quarterly interim dividend of $0.40 per share.
Revenue by Segment
Forward Guidance
Due to the continued uncertainty surrounding COVID-19, STERIS is not providing guidance at this time.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...